A look at what's coming to Contemporary OB/GYN® this week.
Eating disorders carry many risks. An investigation looks into whether they can increase the risk of certain neurodevelopmental conditions in the children of mothers with a history of eating disorders.
The latest trial results showed statistically significant improvements in overall survival and progression-free survival.
Agile Therapeutics, Inc. recently announced a new alliance with Afaxys Pharma, LLC to promote levonorgestrel and ethinyl estradiol (Twirla®) transdermal system.
Check back soon for additional updates.
Regulatory T cell alterations in early pregnancy linked to spontaneous preterm labor
February 18th 2025A recent study reveals that specific Treg subpopulation changes in the first trimester may contribute to spontaneous preterm labor, shedding light on the role of immune regulation in pregnancy outcomes.
Read More
Late third-trimester ultrasound accurately predicts large for gestational age births
February 17th 2025A new study confirms that estimating fetal weight with ultrasound between 35 to 38 weeks’ gestation strongly predicts large for gestational age births, helping guide clinical management decisions.
Read More